Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-02-17 @ 4:38 PM
Study NCT ID:
NCT01619332
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2012-06-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-12
First Submit QC Date:
None
Study First Post Date:
2012-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-05-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-17
Last Update Post Date Type:
ACTUAL